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In view of the potent oxidizing strength of cytochrome P450 intermediates, it 
is not surprising that certain substrates can give rise to reactive species 
capable of attacking the heme or critical distal-pocket protein residues to 
irreversibly modify the enzyme in a process known as mechanism-based (MB) 
inactivation, a result that can have serious physiological consequences leading 
to adverse drug−drug interactions and toxicity. While methods exist to 
document the attachment of these substrate fragments, it is more difficult to 
gain insight into the structural basis for the altered functional properties of 
these modified enzymes. In response to this pressing need to better 
understand MB inhibition, we here report the first application of resonance 
Raman spectroscopy to study the inactivation of a truncated form of 
mammalian CYP2B4 by the acetylenic inhibitor 4-(tert-butyl)phenylacetylene, 
whose activated form is known to attach to the distal-pocket T302 residue of 
CYP2B4. 
Membrane-bound human cytochromes P450, which are 
responsible for catalyzing the metabolism of pharmaceuticals or other 
xenobiotics,1 proceed through a complex cycle involving the sequential 
delivery of two electrons to a heme-bound dioxygen complex, effecting 
the splitting of the O−O bond to generate a potent oxygenating 
intermediate capable of inserting a single oxygen atom into the bound 
substrates, the nature of the putative intermediate generally being 
formulated as a ferryl heme π-cation similar to the Compound I 
species in the enzymatic cycles of the heme peroxidases.1 In view of 
the impressive oxidizing strength of this species, it is not surprising 
that certain substrates give rise to reactive intermediates capable of 
attacking the heme or critical distal-pocket protein residues to 
irreversibly modify the enzyme in a process known as mechanism-
based (MB) inactivation.2 Some of the common compounds that fall 
into the category of MB inactivators are acetylenes, organosulfur 
compounds, arylamines, and others.2 
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Obviously, inasmuch as such irreversible inactivation can have 
profound physiological consequences leading to adverse drug−drug 
interactions or toxicity, it is important to gain structural insight into 
the altered functional behavior of these modified P450s. One of the 
most powerful techniques available for this purpose is resonance 
Raman (RR) spectroscopy, which is able to provide critical information 
about the heme active-site structure, including reliable documentation 
of the iron oxidation and spin states3 and the disposition of bound 
exogenous ligands, permitting characterization of unstable 
intermediates such as the oxy, peroxo, and hydroperoxo intermediates 
that arise in the P450 cycle.3-6 In response to the pressing need to 
better understand MB inhibition, we here report the first application of 
RR to study the inactivation of a truncated form of mammalian CYP2B4 
by the acetylenic inhibitor 4-(tert-butyl)phenylacetylene (BPA), whose 
activated form is known to attach to the distal-pocket T302 residue of 
CYP2B4 (Figure S1 in the Supporting Information).7 
The high-frequency RR spectra of the wild-type substrate-free 
ferric enzyme (WT 2B4dH SF) and its adduct with the prototypical 
substrate benzphetamine (WT 2B4dH BZ) are shown in Figure 1. The 
spectrum of the SF sample (trace A) exhibits the oxidation-state 
marker mode ν4 at 1372 cm−1 and the ν3 and ν2 spin-state markers at 
1502 and 1583 cm−1, respectively, confirming the presence of a ferric 
low-spin state.3,8 The addition of BZ (trace B) causes partial spin-state 
conversion (seen as an increase in the intensity of the high-spin ν3 
mode at 1487 cm−1) associated with disruption of the distal-pocket 
water cluster, entirely consistent with the RR data previously reported 
for full-length ferric substrate-free and BZ-bound cytochrome 2B4.9 
The spectrum of the BPA-modified 2B4dH without added substrate 
(modified 2B4dH SF, trace C) exhibits a spectral pattern essentially 
identical to that of the WT sample, indicating that the enzyme 
modification has no substantial impact on the resting-state heme 
structure. The first interesting observation is that addition of substrate 
(BZ) to BPA-modified 2B4dH causes no changes in the heme spin state 
or macrocyclic core structure, as judged by the virtually identical RR 
spectra (traces C and D), the lack of such changes for the modified 
form being consistent with the blocking of substrate access by the 
attached BPA fragment.7 As shown in Figure S2, the low-frequency RR 
spectral data also confirm the lack of significant changes associated 
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with the attached fragment and the apparent blocking of BZ access to 
the active site. 
 
Figure 1. High-frequency resonance Raman spectra of (A, B) ferric wild-type 
cytochrome 2B4 (WT 2B4dH) and (C, D) modified cytochrome 2B4 (modified 2B4dH): 
(A, C) substrate-free (SF); (B, D) in the presence of benzphetamine (BZ). All of the 
spectra were measured with the 406 nm excitation line at room temperature. Spectra 
normalized to the ν4 mode at (A, C, D) 1372 and (B) 1371 cm−1. 
It is also of obvious importance to interrogate the ligated forms 
of this modified protein. While the oxy and reduced oxy intermediates 
are generally quite unstable,1 the stable ferrous CO form is readily 
characterized by RR measurements. This form mimics the 
physiologically relevant oxy form, providing important information 
about the heme moiety and distal side-pocket structure that can affect 
ligand−protein interactions.8-16 Figure 2 shows the low-frequency RR 
spectra of the CO adducts, where the ν(Fe−CO) stretching and 
δ(Fe−C−O) bending modes are observed, and the high-frequency 
region containing the ν(C−O) mode. The spectrum of WT 2B4dH SF 
exhibits a strong ν(Fe−CO) stretching mode at 471 cm−1 and a 
δ(Fe−C−O) bending mode at 558 cm−1 (trace A), with the 
corresponding ν(C−O) mode occurring at 1950 cm−1. Addition of BZ 
causes a small 2 cm−1 downshift of the ν(Fe−CO) mode (trace B), the 
magnitude of the shift being similar to those observed previously in 
full-length 2B4;9 the ν(C−O) mode shifts upward slightly to 1953 
cm−1. Of greatest significance is the relatively large 6 cm−1 downshift 
of the Fe−CO mode observed for modified 2B4 SF (trace C), with the 
corresponding ν(C−O) stretching mode being upshifted by 9 cm−1 to 
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1959 cm−1; both shifts imply a substantial decrease in distal heme-
pocket polarity and weakening of any possible H-bonding interactions. 
These data provide the first direct spectroscopic evidence that the 
fragment is positioned in such a way as to impact the disposition of 
bound exogenous ligands, which is presumably also relevant for the 
dioxygen adduct and the key peroxo and hydroperoxo fragments. 
Finally, the addition of BZ to the modified protein sample (trace D) 
does not affect the Fe−CO mode (the difference pattern for the spectra 
of the modified protein with and without BZ is featureless), a result 
that further supports the conclusion drawn from study of the ferric 
forms (Figure 1) that the attached BPA fragment blocks the entrance 
of substrate into the heme cavity. 
 
Figure 2. RR spectra of ferrous CO adducts of (A, B) WT and (C, D) modified 2B4dH: 
(A, C) substrate-free; (B, D) in the presence of BZ. The spectra were measured with 
442 nm excitation at room temperature. The inset shows the inverse correlation 
between ν(C−O) and ν(Fe−CO) (diamonds, P450cam;8,13-16 triangles, P450 2B4). 
In addition to these changes in the Fe−C−O fragment, careful 
spectroscopic interrogation of these samples revealed additional 
changes in the “vinyl bending” modes. In the case of WT 2B4dH (trace 
A) there are two vinyl bending modes, at 410 and 419 cm−1, whereas 
in the spectrum of the modified protein (trace C), there is only one 
vinyl bending mode at 418 cm−1, the lower-frequency mode having 
apparently shifted to a position near the higher one. Similar behavior 
was seen in the high-frequency region, where ν(C═C) stretching 
modes are observed: in the spectra of the modified protein, the lower-
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frequency mode at 1620 cm−1 loses intensity while the mode at 1634 
cm−1 gains intensity relative to the spectra of the WT protein (Figure 
S3). The lower-frequency vinyl bending and stretching modes are 
commonly associated with the in-plane configuration of vinyl groups, 
while the higher-frequency bands are associated with out-of-plane 
orientations.17 This demonstrated ability to document changes in these 
vinyl bending and stretching modes is therefore of special importance, 
as the orientation of the vinyl groups with respect to the plane of the 
heme macrocyle has been suggested to carry functional significance by 
modifying the heme reduction potential and affinity for axial 
ligands.18,19 
The changes seen in the behavior of the modes of the Fe−C−O 
fragment are useful indicators of distal-pocket structure.10-16 The 
ν(Fe−CO) and ν(C−O) stretching frequencies in heme proteins usually 
follow an inverse correlation that reflects Fe−CO back-bonding, as 
shown in the inset of Figure 2.10-16 The magnitudes of such shifts are 
influenced by the strength of the trans-proximal ligand bond and the 
polarity of the distal-pocket environment, i.e., positive charge 
(including H bonding) increases the ν(Fe−CO) frequencies and 
decreases the ν(C−O) frequencies along the correlation, while its 
elimination has the opposite effect.10-16 The comparison of the newly 
obtained data for the CO adducts of modified 2B4 with previously 
published data locates the ν(Fe−CO)/ν(C−O) points obtained for the 
samples studied here (dotted line, Figure 2 inset) only slightly below 
the line previously derived for cytochrome P450cam samples (solid 
line, Figure 2 inset); the implied strongly nonpolar environment on the 
distal site of the heme moiety is obviously most reasonably associated 
with the presence of the attached apolar BPA fragment. 
In summary, the acquired RR data confirm that the BPA 
modification of 2B4dH protein does not substantially alter the resting-
state heme structure but does block the BZ substrate from entrance to 
the distal pocket. Most importantly, the present studies of the CO-
ligated forms convincingly demonstrate the impressive potential of RR 
spectroscopy to effectively document even small structural changes 
associated with MB inhibition, including alterations in axial-ligand 
disposition, heme macrocycle deformation, and variations in vinyl 
group orientation, changes that could potentially lead to differences in 
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reduction potential or affinity for axial ligands and impact the stability 
of key peroxo and hydroperoxo intermediates. 
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